Viewing Study NCT02700893


Ignite Creation Date: 2025-12-25 @ 1:01 AM
Ignite Modification Date: 2026-01-03 @ 4:06 AM
Study NCT ID: NCT02700893
Status: COMPLETED
Last Update Posted: 2019-08-09
First Post: 2016-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cerebral NIRS Profiles During Premedication for Neonatal Intubation
Sponsor: Centre Hospitalier Intercommunal Creteil
Organization:

Study Overview

Official Title: Cerebral NIRS Profiles During Premedication for Neonatal Intubation
Status: COMPLETED
Status Verified Date: 2019-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Observational ancillary study of the PRETTINEO study (ClinicalTrials.gov Identifier: NCT01490580) which is a multicenter double blind randomized controlled trial comparing "atropine+propofol" vs "atropine+atracurium+sufentanil" as a premedication prior to endotracheal intubation of the neonate.

Primary outcome:

* Cerebral desaturation defined by a rScO2 delta \>20% from the baseline value (before premedication).
* Variation of more than 10% of cerebral FTOE (Fractional Tissue Oxygen Extraction) during premedication, calculated from rScO2 and pulse oximetry with the formula FTOE=SaO2 - rScO2/SaO2 .

Hypothesis: "atropine + propofol" compared to "atropine+atracurium+sufentanil" does not increase the frequency of cerebral hypoxemia.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: